Assertio Holdings (ASRT) Non Operating Income (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Non Operating Income came in at -$341000.0 in Q1 2026, down 441.27% year-on-year from $99920.9 in Q1 2025, and down 11466.67% quarter-over-quarter from $3000.0 in Q4 2025.
Assertio Holdings (ASRT) Non Operating Income (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Non Operating Income across 8 years of filings, most recently posting -$341000.0 for Q1 2026.
- Non Operating Income for Q1 2026 came in at -$341000.0, down 441.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$8.7 million (down 396.72% YoY), and the FY2025 annual result was -$8.4 million, down 385.17% from the prior year.
- Non Operating Income came in at -$341000.0 for Q1 2026 at Assertio Holdings, down from $3000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $2.7 million in Q4 2024 to a low of -$10.4 million in Q4 2023.
- The 5-year median for Non Operating Income is -$63000.0 (2025), against an average of -$1.8 million.
- Across the five-year window, Non Operating Income slumped 30800.0% in 2023 and soared 736.36% in 2024, its largest moves.
- Assertio Holdings' Non Operating Income stood at -$2.0 million in 2022, then tumbled by 409.1% to -$10.4 million in 2023, then jumped by 126.19% to $2.7 million in 2024, then sank by 99.89% to $3000.0 in 2025, then plunged by 11466.67% to -$341000.0 in 2026.
- The last three Non Operating Income figures came in at -$341000.0 (Q1 2026), $3000.0 (Q4 2025), and -$80000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | -341,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -341,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | -80,000.00 |
| Jun 30, 2025 | -8.26 Mn |
| Mar 31, 2025 | -63,000.00 |
| Dec 31, 2024 | 2.73 Mn |
| Sep 30, 2024 | 171,000.00 |
| Jun 30, 2024 | 92,000.00 |
| Mar 31, 2024 | -41,000.00 |
| Dec 31, 2023 | -10.41 Mn |
| Sep 30, 2023 | -614,000.00 |
| Jun 30, 2023 | 11,000.00 |
| Mar 31, 2023 | -10.24 Mn |
| Dec 31, 2022 | -2.04 Mn |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | -2.36 Mn |
| Mar 31, 2022 | 545,000.00 |
| Dec 31, 2021 | -504,000.00 |
| Sep 30, 2021 | 344,000.00 |
| Jun 30, 2021 | -2.47 Mn |